Navigation Links
Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
Date:4/8/2008

mpairs the person's ability to carry out their daily responsibilities because they are too tired or have trouble concentrating.

Insomnia has a variety of causes. It is often a symptom of some other disease or condition (e.g. life stress, psychiatric and medical disorders, or use of certain medications), but it can also be a distinct disorder. The prevalence of insomnia increases with age and is more common in women. Common symptoms of acute insomnia are sleepiness, negative mood and impairment of performance. Chronic insomnia is often associated with fatigue, mood changes, difficulty concentrating and impaired daytime functioning.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the continued development of APD125; the protocol, design, scope, enrollment, number, timing and other aspects of clinical trials of APD125; the timing of the results from the Phase 2b clinical trial of APD125 and expectations related to such results; the tolerability, side effects, safety profile, efficacy and the
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... MENLO PARK, Calif. , Aug. 27, 2014 /PRNewswire/ ... of advanced cancer therapeutics , will be featured as ... Renshaw Global Investment Conference, sponsored by H.C. Wainwright ... September 9th at 2:55 p.m. EDT in the Kennedy ... Hotel in New York City . ...
(Date:8/27/2014)... Aug. 27, 2014 About 8 million Americans ... to buildup of fatty plaque in the arteries, according ... patient population and in incidences of diabetes and obesity, ... Lower Extremity Arterial RevascularizatioN (LEARN) meeting, Oct. ... specialists and interested residents and fellows will be able ...
(Date:8/27/2014)... Aug. 27, 2014 Research and Markets ... Oximeter Industry Report 2014" report to their offering. ... 2014 is a professional and in-depth study on the ... The report provides a basic overview of the ... The pulse oximeter market analysis is provided for the ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Global Pulse Oximeter Industry Report 2014 2
(Date:8/27/2014)... August 27, 2014 Sound Telecom, a ... solutions, and cloud-based business communication systems, has unveiled an ... about HIPAA-compliant Secure Text Messaging .” The piece examines ... need to do to remain compliant with HIPAA and ... the article and C.O.O. at Sound Telecom, opens with ...
(Date:8/27/2014)... August 27, 2014 Dr. Stewart ... Center see multitudes of patients suffering from impaired vision. ... Cataract vision correction surgery . Recently, Dr. Shofner ... information during an eye exam and also online. To ... top five myths about glaucoma. , 1)    Myth: People with ...
(Date:8/27/2014)... ANS is pleased to ... anti-cancer therapy for the treatment of recurrent glioblastoma (GBM). ... new medical therapy and will begin extending this new ... NovoTTF™ Therapy is a portable, non-invasive anti-mitotic system approved ... age and older. It is a treatment option for ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The federal ... http://www.consumerinjurylawyers.com/DePuy/ ) has extended the deadline for plaintiffs to ... August 2014 Order issued by U.S. District Judge David ... to enroll in the DePuy ASR Settlement Program must ... Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – ...
(Date:8/27/2014)... August 27, 2014 Parker Waichman LLP, ... rights of victims injured by defective medical devices, reports ... for discovery procedures, specifically Collection and Preservation of Evidence, ... transvaginal mesh devices. (MDL No. 2187, In Re: C.R. ... United States District Court, Southern District or West Virginia; ...
Breaking Medicine News(10 mins):Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:Atlantic NeuroSurgical Specialists (ANS) Announces Availability of New Therapy for Brain Cancer 2Health News:Atlantic NeuroSurgical Specialists (ANS) Announces Availability of New Therapy for Brain Cancer 3Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4
... BEIJING, June 9 /PRNewswire-Asia/ -- RainEarth ... its,contractual partner in China, Beijing RainEarth Technology Co. Ltd., ... generation of,blood dialysis. , This ... These include: a lower broken membrane rate, a higher ...
... and Disability products, vision and dental expand cost-effective solutions ... June 9 Empire BlueCross BlueShield (Empire) today announced ... begin offering Life and Disability insurance as part of ... affiliate, Anthem Life & Disability Insurance Company, this addition ...
... 9 In his Saturday weekly radio address, President Obama referred to ... untrue. , , The truth is that healthcare spending ... increased by 10% in 1970 and 13% in 1980. But over ... reached a low of 6% in 2007. For more of ...
... solutions while asleep, study suggests , TUESDAY, June 9 (HealthDay ... sleep on it, researchers suggest. , In a study from ... researchers say that rapid eye movement (REM) sleep boosts ... the brain. , "We found that -- for creative problems ...
... Less Than One in Five Employers Offer Stand Alone Vision ... VSP(R) Vision Care launched the industry,s first ... it grow to more than 25,000 members nationwide. In a ... economy on health and vision care priorities and costs, VSP ...
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) ... the trade. Calcitonin-salmon nasal spray is a generic version ... Miacalcin were approximately $112 million in 2008, according to IMS ... about calcitonin-salmon nasal spray , , Calcitonin-salmon nasal ...
Cached Medicine News:Health News:RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 2Health News:RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 3Health News:Empire BlueCross BlueShield Adds Life Insurance, Becomes Full-Service Benefits Provider 2Health News:Empire BlueCross BlueShield Adds Life Insurance, Becomes Full-Service Benefits Provider 3Health News:Empire BlueCross BlueShield Adds Life Insurance, Becomes Full-Service Benefits Provider 4Health News:Got a Problem? Think About It Overnight 2Health News:VSP's Individual Plan Thrives in a Starving Economy 2Health News:VSP's Individual Plan Thrives in a Starving Economy 3Health News:Par Pharmaceutical Begins Shipment of Generic Miacalcin(R) 2
... innovator of suction products in the U.S. ... and assure that their quality meets or ... and directly support our full line of ... and Poole Tip Suction handles, suction canisters, ...
Touch-Trol Suction Catheter Mini-Tray...
SAFE-T-VAC Coil Packed Suction Catheters Kits, Sterile without Solution...
Suction Catheter Kits with Sterile Saline (Bottle)...
Medicine Products: